CPC A61K 31/365 (2013.01) [A61K 36/53 (2013.01); A61P 31/14 (2018.01); A61K 2236/35 (2013.01); A61K 2236/39 (2013.01)] | 8 Claims |
1. A method for inhibiting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which comprises administering a safe and effective amount of Formula I compound—Ovatodiolide or a safe and effective amount of structural isomer of the Formula I compound—Ovatodiolide to a subject,
![]() |